Results 31 to 40 of about 280,810 (293)

Transanal endoscopic microsurgery in the treatment of patients with benign neoplasms and early rectal cancer

open access: yesСибирский онкологический журнал, 2022
Introduction. Transanal endoscopic microsurgery (tem) is a method that allows the specialists to clearly visualize a tumor and bimanually remove the tumor using a set of special instruments.
V. A. Avdeenko   +10 more
doaj   +1 more source

Clinical study of colorectal cancer operation: Survival analysis [PDF]

open access: yesKorean Journal of Clinical Oncology, 2020
Purpose Overall 5-year survival rates for colon and rectal cancer reported recently by the American Cancer Society were 89%, 90% for localized disease, 71%, 71% for regional disease, and 14%, 15% for distant disease.
Youngki Hong   +3 more
doaj   +1 more source

Bowel Preparation for Surveillance Colonoscopy After Colorectal Resection: A New Perspective [PDF]

open access: yesAnnals of Coloproctology, 2019
Purpose Inadequate bowel preparation (IBP) is commonly observed during surveillance colonoscopy after colorectal resection. We investigated potential risk factors affecting bowel preparation.
Donghyoun Lee, Ho-Kyung Chun
doaj   +1 more source

A rare case of rectal adenocarcinoma and small-bowel neuroendocrine tumor in a young patient with long-standing Crohn's disease: A case report

open access: yesJournal of Nature and Science of Medicine, 2021
Background: The association of adenocarcinoma of the colon and neuroendocrine tumor (NET) of the small bowel has been previously described in Crohn's disease (CD), however the concomitance of both neoplasms is extremely rare.
Nahla Azzam
doaj   +1 more source

Liver metastasis from rectal neuroendocrine neoplasm detected 15 years after primary resection

open access: yesSurgical Case Reports, 2022
Background Rectal neuroendocrine neoplasms can induce liver metastasis. However, few reports exist on the associated long-term recurrence rates. We report a case of liver metastasis identified 15 years after rectal neuroendocrine neoplasm resection. Case
Miho Akabane   +5 more
doaj   +1 more source

Role of endoscopic submucosal dissection in treatment of rectal gastroenteropancreatic neuroendocrine neoplasms

open access: yes, 2016
Introduction : A significant rise in incidence of rectal gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) has been observed in the last decade.
Włodzimierz Koptas   +3 more
core   +1 more source

DMMR status and synchronous lesions predicts metachronous lesions after curative resection for rectal cancer

open access: yesFrontiers in Surgery
BackgroundThere are no established standard colonoscopy surveillance protocols for patients after curative rectal cancer resection. We investigated the predictive factors for colorectal neoplasms during surveillance colonoscopies to identify patients who
Xijie Chen   +22 more
doaj   +1 more source

Clinical outcomes of local excision following preoperative chemoradiotherapy for locally advanced rectal cancer

open access: yes, 2018
Local excision; Preoperative chemoradiotherapy; Rectal neoplasms ...
이경자
core   +1 more source

Inhibition of cyclin‐dependent kinases 12/13 using CT7439 as a treatment for colorectal cancer with CDK12 upregulation

open access: yesMolecular Oncology, EarlyView.
The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington   +10 more
wiley   +1 more source

Neoadjuvant treatment in locally advanced rectal cancer

open access: yes, 2015
The optimal treatment for locally advanced rectal cancerremains an issue of debate. The surgery with total mesorectalexcision (TME) still is the standard of care.
KAYTAN SAGLAM, Esra, AKGUN, Zuleyha
core   +2 more sources

Home - About - Disclaimer - Privacy